Medical-device maker said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

The medial device company claimed that the Apple Watch Series ... However, in October 2022 Apple sued medical technology ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...

and the jury’s verdict is a victory for Masimo on that issue,” the medical device company said. The trial resulted from Apple’s countersuit in its ongoing legal battle with Masimo ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...